Andrew A. F. Hack, Director at Atea Pharmaceuticals, Inc. (AVIR), bought 5,615,659 shares at $24.00 ($6.0M) on 2020-11-03, disclosed to the SEC on 2020-11-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,365,659 | $0 | 0.0% |
| 2 | $24.00 | 250,000 | $6.0M | 100.0% |
| Total | $1.07 avg | 5,615,659 | $6.0M | 100% |
| Filing → |
| DVAX | SELL | 2023-08-10 | $21.6M | — | Filing → |
| DVAX | SELL | 2023-06-16 | $6.3M | — | Filing → |
| DVAX | SELL | 2023-05-19 | $10.6M | — | Filing → |